Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin D Pavelko

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Molecular Cancer Therapeutics|January 30, 2016
Enhancing the Tumor Selectivity of a Picornavirus Virotherapy Promotes Tumor Regression and the Accumulation of Infiltrating CD8+ T CellsMichael P Bell, Kevin D Pavelko
Cancer Research|November 4, 2010
Retraction: CTL activation using the natural low-affinity epitope 222-229 from tyrosinase-related protein 1 leads to tumor rejectionKevin D Pavelko, Michael J Hansen, Larry R Pease
Cancer Research|March 12, 2009
CTL activation using the natural low-affinity epitope 222-229 from tyrosinase-related protein 1 leads to tumor rejectionKevin D Pavelko, Michael J Hansen, Larry R Pease
Frontiers in Immunology|November 25, 2017
B7-H1 Influences the Accumulation of Virus-Specific Tissue Resident Memory T Cells in the Central Nervous SystemKevin D Pavelko, Michael P Bell, Susan M Harrington, et al.
Brain Pathology (Zurich, Switzerland)|March 29, 2007
Genetic deletion of a single immunodominant T-cell response confers susceptibility to virus-induced demyelinationKevin D Pavelko, Larry R Pease, Chella S David, et al.
Cancer Research|November 4, 2010
Retraction: An effective vaccine strategy protective against antigenically distinct tumor variantsKevin D Pavelko, Michael J Hansen, Larry R Pease, et al.
Cancer Research|April 3, 2008
An effective vaccine strategy protective against antigenically distinct tumor variantsKevin D Pavelko, Karin L Heckman, Michael J Hansen, et al.
Viral Immunology|July 16, 2014
A CD8 T-cell epitope variant enhances immune targeting to a recombinant picornavirus vaccine antigenMichael P Bell, Danielle N Renner, Aaron J Johnson, et al.
Plos One|April 9, 2014
An elite controller of picornavirus infection targets an epitope that is resistant to immune escapeMichael P Bell, Danielle N Renner, Aaron J Johnson, et al.
Allergy|December 28, 2020
Mass cytometry reveals unique subsets of T cells and lymphoid cells in nasal polyps from patients with chronic rhinosinusitis (CRS)Kathleen R Bartemes, Garret Choby, Erin K O'Brien, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Molecular Cancer Therapeutics|January 30, 2016
Enhancing the Tumor Selectivity of a Picornavirus Virotherapy Promotes Tumor Regression and the Accumulation of Infiltrating CD8+ T CellsMichael P Bell, Kevin D Pavelko
Cancer Research|November 4, 2010
Retraction: CTL activation using the natural low-affinity epitope 222-229 from tyrosinase-related protein 1 leads to tumor rejectionKevin D Pavelko, Michael J Hansen, Larry R Pease
Cancer Research|March 12, 2009
CTL activation using the natural low-affinity epitope 222-229 from tyrosinase-related protein 1 leads to tumor rejectionKevin D Pavelko, Michael J Hansen, Larry R Pease
Frontiers in Immunology|November 25, 2017
B7-H1 Influences the Accumulation of Virus-Specific Tissue Resident Memory T Cells in the Central Nervous SystemKevin D Pavelko, Michael P Bell, Susan M Harrington, et al.
Brain Pathology (Zurich, Switzerland)|March 29, 2007
Genetic deletion of a single immunodominant T-cell response confers susceptibility to virus-induced demyelinationKevin D Pavelko, Larry R Pease, Chella S David, et al.
Cancer Research|November 4, 2010
Retraction: An effective vaccine strategy protective against antigenically distinct tumor variantsKevin D Pavelko, Michael J Hansen, Larry R Pease, et al.
Cancer Research|April 3, 2008
An effective vaccine strategy protective against antigenically distinct tumor variantsKevin D Pavelko, Karin L Heckman, Michael J Hansen, et al.
Viral Immunology|July 16, 2014
A CD8 T-cell epitope variant enhances immune targeting to a recombinant picornavirus vaccine antigenMichael P Bell, Danielle N Renner, Aaron J Johnson, et al.
Plos One|April 9, 2014
An elite controller of picornavirus infection targets an epitope that is resistant to immune escapeMichael P Bell, Danielle N Renner, Aaron J Johnson, et al.
Allergy|December 28, 2020
Mass cytometry reveals unique subsets of T cells and lymphoid cells in nasal polyps from patients with chronic rhinosinusitis (CRS)Kathleen R Bartemes, Garret Choby, Erin K O'Brien, et al.
Pageof 7